Matinas BioPharma Holdings, Inc.

Enabling the Delivery of Life-Changing Medicines

Our differentiated lipid nano-crystal (LNC) drug delivery platform has the potential to address delivery issues associated with a range of molecules.

Learn More About Our LNC Platform

Mechanism of Action Video

MAT9001: Prescription-Only Next Generation Omega-3

MAT9001 is our proprietary prescription-only omega-3 fatty acid-based composition under development for the treatment of cardiovascular and metabolic conditions

Learn More about MAT9001

Comparative Study Results

Stock Snapshot

NYSE American





Investor Presentation

Investor Presentation

View our latest Corporate Presentation

Download Presentation »